LYTIR

Insider · SEC Form 4 · President, R&D

Crystal Adam

In the 12 months to Nov 8, 2026, on the open market: sold $2.9M of TNGX. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $2.9M in total.Jul: Insider sales $799KAug: Insider sales $736KSep: Insider sales $604KOct: Insider sales $661KNov: Insider sales $112KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $2.9M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. TNGXSold: Tango Therapeutics, Inc. Nov 2, 2026 5,000 shares filed Nov 4, 2026 2 transactions 10b5-1 plan filing $112K
  2. TNGXSold: Tango Therapeutics, Inc. Oct 1, 2026 27,000 shares filed Oct 5, 2026 2 transactions 10b5-1 plan filing $661K
  3. TNGXSold: Tango Therapeutics, Inc. Sep 1, 2026 27,000 shares filed Sep 3, 2026 115,743 shares held directly after, as filed 10b5-1 plan filing $604K
  4. TNGXSold: Tango Therapeutics, Inc. Aug 3, 2026 27,000 shares filed Aug 5, 2026 2 transactions 10b5-1 plan filing $736K
  5. TNGXSold: Tango Therapeutics, Inc. Jul 1, 2026 27,000 shares filed Jul 2, 2026 2 transactions 10b5-1 plan filing $799K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • TNGX: option exercise or conversion (code M), 5 entries, Jul 1 to Nov 2, 2026
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.